Digest Network How does it work
Network
/
Society
C₂
Not verified

C₂N Diagnostics, LLC

What we write about

BiotechnologyHealthIndustriaMedical and healthScienza

10 Press releases

View all press releases
13/03/2025
Labour market
Medical and health
Health
Sanità
Biotechnology
Samsung Invests in C2N Diagnostics
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
24/02/2025
Biotechnology
Medical and health
Sanità
Health
Medicine - various
Industria
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
31/01/2025
Scienza
Biotechnology
Sanità
Health
Psychiatry
Medicine - various
Market analysis
Industria
Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
28/01/2025
Scienza
Biotechnology
Medical and health
Health
Psychiatry
Industria
First Canadian Clinic to Offer C2N’s PrecivityAD2™ Blood Test to Help Healthcare Providers Diagnose Alzheimer’s Disease, Joining Global Community in Embracing Breakthrough Technology
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
15/01/2025
Industria
Scienza
Sanità
Nuclear medicine
Associations / Professional
Psychiatry
Biotechnology
Medicine - various
Health
C2N Diagnostics Partners with The Michael J. Fox Foundation to Uncover New Links Between Parkinson’s Disease, Lewy Body Dementia and Alzheimer’s Disease
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
30/09/2024
Industria
Biotechnology
Health
Sanità
Nuclear medicine
Psychiatry
Scienza
Medicine - various
C2N Diagnostics Receives $15 Million Program Related Investment from GHR Foundation to Develop Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
25/09/2024
Labour market
Industria
Scienza
Biotechnology
Pharmaceuticals
Health
Medical and health
Medicine - various
C2N Receives Funding from Diagnostics Accelerator to Develop a Decentralized Clinical Mass Spectrometry Solution to Enable High-Performance Alzheimer’s Disease Testing Worldwide
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
07/08/2024
Medical and health
Biotechnology
Health
Third age
Pharmaceuticals
Psychiatry
Scienza
Windows / Shopping
Labour market
C2N Diagnostics and Unilabs Announce Global Partnership, Bringing Together Innovation Leaders in Diagnostics and Laboratory Medicine to Advance Brain Health
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
28/07/2024
Medical and health
Health
Scienza
Biotechnology
Industria
JAMA Publishes Landmark Clinical Study Showing C2N Diagnostics’ PrecivityAD2™ Blood Test Markedly Improves Accuracy of AD Diagnosis in Both Primary Care and Specialized Memory Care
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0
27/06/2024
Labour market
Industria
Scienza
Pharmaceuticals
Windows / Shopping
Psychiatry
Biotechnology
Third age
Medical and health
Management
Health
C2N’s Precivity™ Tests are Now Offered Through Mayo Clinic Laboratories
Source
C₂N Diagnostics, LLC
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0